CONFERENCE UPDATE: ASCO 2022

Updated analysis from ECHELON-1: OS with brentuximab vedotin + chemotherapy in advanced cHL patients

Glossary: cHL: Classical Hodgkin lymphoma; CI: Confidence interval; ECOG: Eastern Cooperation Oncology Group; HL: Hodgkin lymphoma; HR: Hazard ratio; IV: Intravenous; OS: Overall survival; PFS: Progression-free survival; PN: Peripheral neuropathy; PS: Performance status; TN: Treatment-naïve

Get access to our exclusive articles.
Related Articles